IN THIS ISSUE

Peer-Reviewed
Mark Zitter, MBA
This article evaluates recent trends and challenges in health system management of exceedingly rare genetic diseases, from the perspective of the manufacturer, managed care organization, physician, and actuary.
Legislation & Regulation
John Carroll
How much will plans have to "be like Mike" — Leavitt, that is. The influence of the secretary of health and human services reaches beyond the public sector.
Employer Update
MargaretAnn Cross
Now that large companies are adding health information to their benefit portals on the Web, insurers will have to work more closely with them.
Tomorrow's Medicine
Thomas Morrow, MD
There is very little competition in the biopharmaceutical sector. With the introduction of generic forms of human growth hormone, can managed care get a lower price?
News and Commentary